These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26475964)

  • 21. Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness.
    Moreira J; Almeida J; Saraiva L; Cidade H; Pinto M
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34205272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
    Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
    Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma.
    Gomes S; Raimundo L; Soares J; Loureiro JB; Leão M; Ramos H; Monteiro MN; Lemos A; Moreira J; Pinto M; Chlapek P; Veselska R; Sousa E; Saraiva L
    Cancer Lett; 2019 Apr; 446():90-102. PubMed ID: 30664963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53-dependent and -independent mechanisms are involved in (E)-1-(2-hydroxyphenyl)-3-(2-methoxynaphthalen-1-yl)prop-2-en-1-one (HMP)-induced apoptosis in HCT116 colon cancer cells.
    Shin SY; Ahn S; Koh D; Lim Y
    Biochem Biophys Res Commun; 2016 Oct; 479(4):913-919. PubMed ID: 27641669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
    Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
    Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53.
    Sorriento D; Del Giudice C; Bertamino A; Ciccarelli M; Gomez-Monterrey I; Campiglia P; Novellino E; Illario M; Trimarco B; De Luca N; Iaccarino G
    Br J Cancer; 2015 Jan; 112(1):77-85. PubMed ID: 25422906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53.
    Ou WB; Lu M; Eilers G; Li H; Ding J; Meng X; Wu Y; He Q; Sheng Q; Zhou HM; Fletcher JA
    Br J Cancer; 2016 Nov; 115(10):1253-1263. PubMed ID: 27736841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma.
    Niotis A; Tsiambas E; Dimitroulis D; Sarlanis H; Falidas E; Kavantzas N; Constantinides CA
    Acta Med Acad; 2023 Apr; 52(1):24-29. PubMed ID: 37326394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.
    Tovar C; Graves B; Packman K; Filipovic Z; Higgins B; Xia M; Tardell C; Garrido R; Lee E; Kolinsky K; To KH; Linn M; Podlaski F; Wovkulich P; Vu B; Vassilev LT
    Cancer Res; 2013 Apr; 73(8):2587-97. PubMed ID: 23400593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma.
    Yi H; Yan X; Luo Q; Yuan L; Li B; Pan W; Zhang L; Chen H; Wang J; Zhang Y; Zhai Y; Qiu MZ; Yang DJ
    J Exp Clin Cancer Res; 2018 May; 37(1):97. PubMed ID: 29716622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
    Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
    Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
    Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
    Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation.
    Mochizuki H; Goto-Koshino Y; Sato M; Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2012 Jun; 147(3-4):187-94. PubMed ID: 22578852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel chalcone derivative, LQFM064, induces breast cancer cells death via p53, p21, KIT and PDGFRA.
    Cabral BLS; da Silva ACG; de Ávila RI; Cortez AP; Luzin RM; Lião LM; de Souza Gil E; Sanz G; Vaz BG; Sabino JR; Menegatti R; Valadares MC
    Eur J Pharm Sci; 2017 Sep; 107():1-15. PubMed ID: 28627468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
    Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
    J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gambogic acid down-regulates MDM2 oncogene and induces p21(Waf1/CIP1) expression independent of p53.
    Rong JJ; Hu R; Qi Q; Gu HY; Zhao Q; Wang J; Mu R; You QD; Guo QL
    Cancer Lett; 2009 Oct; 284(1):102-12. PubMed ID: 19428175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of p53 by MDM2 antagonists can protect proliferating cells from mitotic inhibitors.
    Carvajal D; Tovar C; Yang H; Vu BT; Heimbrook DC; Vassilev LT
    Cancer Res; 2005 Mar; 65(5):1918-24. PubMed ID: 15753391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells.
    Zhou Y; Ho WS
    Oncol Rep; 2014 Jan; 31(1):298-304. PubMed ID: 24247527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.